Stoke Therapeutics Appoints Ian Smith to its Board of Directors

– Mr. Smith brings significant experience in the successful development and commercialization of medicines for rare genetic diseases –

...

Related Keywords

Massachusetts ,United States ,Cambridge ,Cambridgeshire ,United Kingdom ,Bedford ,Edwardm Kaye ,Ian Smith ,Ianf Smith ,Viacyte Inc ,Stoke Therapeutics Inc ,Manchester Metropolitan University United Kingdom ,Augmentation Of Nuclear Gene Output ,Senior Advisor To Bain Capital Life Sciences ,Vexsol Inc ,Nasdaq ,Alkeus Pharmaceuticals ,Vertex Pharmaceuticals ,Stoke Therapeutics ,Chief Executive Officer ,Senior Advisor ,Bain Capital Life Sciences ,Executive Chair ,Solid Biosciences ,Foghorn Therapeutics ,Executive Vice President ,Chief Operating Officer ,Chief Financial Officer ,Manchester Metropolitan University ,Targeted Augmentation ,Nuclear Gene Output ,Markets ,